Prostate Cancer
TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients withMetastatic Castration-resistant Prostate Cancer Associated withHomologous Recombination Deficiency (CO-338-063)
- Details
ClinicalTrials.gov ID:
NCT02975934
Diagnosis Type:
NA
USOR Number:
- Address
1448 East Common St
New
Braunfels, TX 78130
P: (830) 643-1762